Immix Biopharma, Inc. entered into an Underwriting Agreement with Titan Partners Group LLC for an underwritten offering of 5,535,055 shares of common stock, with an estimated gross proceeds of $15 million.
AI Assistant
IMMIX BIOPHARMA INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.